论文部分内容阅读
10月25日,强生(中国)医疗器材有限公司在长城国际心血管会议上重拳出击,隆重推出新一代治疗心血管循环系统疾病的三个新产品:Cypher SelectPlus 药物洗脱支架,Fire Star 预扩球囊和 Dura Sar 后扩球囊。这套最新一代的心血管循环疾病诊疗工具包中的三个产品全部体现了业内现阶段的最高水平,不仅秉承了 Cordis 产品的安全性和有效性,同时产品拥有更加杰出的处理心血管复杂病变的能力,不仅使手术过程更加顺畅,还可以缩短病人的手术时间,为中国患者带来更高的手术舒适度以及更好的术后效果。Cordis 的 Cypher 支架是迄今为止被应用得最广泛的药物洗脱支架。大量的循证数据证实,Cypher 支架能显著提高患者的生活质量,降低疾病负担。截止到2008年,全球已有超过75个针对 Cypher 的临床研究在各地开展,五万位
On October 25, Johnson & Johnson (China) Medical Equipment Co., Ltd. took a heavy blow at the Great Wall International Cardiovascular Conference to launch a new generation of three new products for the treatment of cardiovascular diseases: Cypher SelectPlus stent, Fire Star Dilatation balloon and Dura Sar posterior balloon. The latest generation of cardiovascular disease treatment kit of three products all embody the industry’s highest level at this stage, not only adhering to the safety and effectiveness of Cordis products, while the product has a more outstanding treatment of cardiovascular complex lesions The ability to not only make the operation process smoother, but also can shorten the patient’s operation time for Chinese patients with higher surgical comfort and better postoperative results. Cordis’s Cypher stent is by far the most widely used drug-eluting stent. A large number of evidence-based data confirmed that Cypher stent can significantly improve the quality of life of patients and reduce the burden of disease. As of 2008, more than 75 clinical studies targeting Cypher have been conducted in various regions of the world, with 50,000